A research team led by Arbor Research Collaborative for Health and St. Michael’s Hospital in Toronto was awarded a 5-year contract from the Agency for Healthcare Research and Quality to study peritonitis infection in patients on peritoneal dialysis.
The project aims to identify high-risk patients and clinical practices associated with peritonitis risk to help further inform best practice guidelines for reducing risk. Secondary aims of the study include the creation of a meaningful approach for standardized reporting of peritonitis episodes and the promotion of knowledge dissemination strategies that foster continuous quality improvement activities and clinical treatment pathways for the prevention of peritonitis in peritonitis dialysis (PD) care settings.
“I am thrilled for this important and highly relevant research opportunity,” Jeffrey Perl, MD, a co-principal investigator from St. Michael’s Hospital, said in a press release from the Arbor Research Collaborative for Health. “Many patients prefer home-based peritoneal dialysis, so it is important that we identify and address any issues associated with it and reduce any subsequent risks.”
The project will function as an ancillary study of the Peritoneal Dialysis Outcomes and Practice Patterns Study, reportedly the largest multinational prospective cohort study of PD to date. The study will consist of more than 240 randomly selected PD units and more than 12,000 patients on PD in nine countries.
“We are excited and honored to have the opportunity to carry out this work aimed at decreasing peritonitis rates in the U.S. and more broadly across the world.” Ronald Pisoni, PhD, MS, a co-principal investigator from Arbor Research Collaborative for Health, said in the release.